125 related articles for article (PubMed ID: 9308224)
21. C-Myc transrepression and cell transformation.
Lee LA; Dang CV
Curr Top Microbiol Immunol; 1997; 224():131-5. PubMed ID: 9308236
[No Abstract] [Full Text] [Related]
22. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
[TBL] [Abstract][Full Text] [Related]
23. 25 years of the c-Myc oncogene.
Cole MD; Henriksson M
Semin Cancer Biol; 2006 Aug; 16(4):241. PubMed ID: 16935523
[No Abstract] [Full Text] [Related]
24. Myc meets its Max.
Cole MD
Cell; 1991 May; 65(5):715-6. PubMed ID: 2040011
[No Abstract] [Full Text] [Related]
25. Of mice and Myc: c-Myc and mammary tumorigenesis.
Jamerson MH; Johnson MD; Dickson RB
J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):27-37. PubMed ID: 15082916
[TBL] [Abstract][Full Text] [Related]
26. Definition of the activities and properties of c-myc required to inhibit cell differentiation.
Freytag SO; Dang CV; Lee WM
Cell Growth Differ; 1990 Jul; 1(7):339-43. PubMed ID: 2278885
[TBL] [Abstract][Full Text] [Related]
27. Evidence from transgenic mice that myc regulates hepatic glycolysis.
Valera A; Pujol A; Gregori X; Riu E; Visa J; Bosch F
FASEB J; 1995 Aug; 9(11):1067-78. PubMed ID: 7649406
[TBL] [Abstract][Full Text] [Related]
28. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.
Shchors K; Shchors E; Rostker F; Lawlor ER; Brown-Swigart L; Evan GI
Genes Dev; 2006 Sep; 20(18):2527-38. PubMed ID: 16980582
[TBL] [Abstract][Full Text] [Related]
29. Nfkb 1 is dispensable for Myc-induced lymphomagenesis.
Keller U; Nilsson JA; Maclean KH; Old JB; Cleveland JL
Oncogene; 2005 Sep; 24(41):6231-40. PubMed ID: 15940251
[TBL] [Abstract][Full Text] [Related]
30. Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells.
Lee H; Wu M; La Rosa FA; Duyao MP; Buckler AJ; Sonenshein GE
Curr Top Microbiol Immunol; 1995; 194():247-55. PubMed ID: 7895496
[No Abstract] [Full Text] [Related]
31. Antisense oligodeoxynucleoside methylphosphonate inhibition of mouse c-myc p65 protein expression in E mu-c-myc transgenic mice.
Wickstrom E; Bacon TA; Wickstrom EL; Werking CM; Palmiter RD; Brinster RL; Sandgren EP
Nucleic Acids Symp Ser; 1991; (24):151-4. PubMed ID: 1841270
[TBL] [Abstract][Full Text] [Related]
32. Transient in utero knockout (TIUKO) of C-MYC affects late lung and intestinal development in the mouse.
Cohen JC; Scott DK; Miller J; Zhang J; Zhou P; Larson JE
BMC Dev Biol; 2004 Apr; 4():4. PubMed ID: 15090077
[TBL] [Abstract][Full Text] [Related]
33. The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo.
Osthus RC; Karim B; Prescott JE; Smith BD; McDevitt M; Huso DL; Dang CV
Cancer Res; 2005 Jul; 65(13):5620-7. PubMed ID: 15994934
[TBL] [Abstract][Full Text] [Related]
34. Mnt takes control as key regulator of the myc/max/mxd network.
Wahlström T; Henriksson M
Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of cardiac myocyte division in c-myc transgenic mice.
Machida N; Brissie N; Sreenan C; Bishop SP
J Mol Cell Cardiol; 1997 Jul; 29(7):1895-902. PubMed ID: 9236143
[TBL] [Abstract][Full Text] [Related]
36. The many faces of c-MYC.
Pelengaris S; Khan M
Arch Biochem Biophys; 2003 Aug; 416(2):129-36. PubMed ID: 12893289
[TBL] [Abstract][Full Text] [Related]
37. Oncogene addiction: sometimes a temporary slavery.
Jonkers J; Berns A
Cancer Cell; 2004 Dec; 6(6):535-8. PubMed ID: 15607957
[TBL] [Abstract][Full Text] [Related]
38. Complementation of Myc-dependent cell proliferation by cDNA expression library screening.
Nikiforov MA; Kotenko I; Petrenko O; Beavis A; Valenick L; Lemischka I; Cole MD
Oncogene; 2000 Oct; 19(42):4828-31. PubMed ID: 11039899
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of tumorigenesis in a murine B-cell lymphoma transplant model by c-Myc complementary oligonucleotides.
Smith JB; Wickstrom E
Adv Exp Med Biol; 1998; 451():17-22. PubMed ID: 10026844
[No Abstract] [Full Text] [Related]
40. Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER mice.
Blyth K; Stewart M; Bell M; James C; Evan G; Neil JC; Cameron ER
Oncogene; 2000 Feb; 19(6):773-82. PubMed ID: 10698495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
